Watch WLKP. Know when insiders buy.
One email the day a filing lands. Free.
WLKP
Westlake Chemical Partners LP
21.27
+0.01 +0.05%
USD · close Oct 2
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
24
FLAG · shorts 24
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $749.7MP/E —DIV YIELD —FCF YIELD 54.58%REV TTM $1.2B +12.1%NET INCOME $57.6M +9.4%NET CASH —52W 17.87 – 23.72SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $297.1M | −0.0% | 31.9% | $87.3M | $14.2M | −2.2% | — | $129.8M | $12.5M | $117.4M | Aug 5 |
| Q1 2026 · Mar 31 | $305.7M | +28.6% | 30.7% | $86.6M | $14.2M | +186.4% | — | $110.2M | $5.6M | $104.6M | May 6 |
| Q4 2025 · Dec 31derived | $323M | +11.4% | 30.0% | $89.8M | $14.5M | −3.0% | — | $120.4M | $8.8M | $111.5M | Mar 4 |
| Q3 2025 · Sep 30 | $308.9M | +11.5% | 32.2% | $92M | $14.7M | −19.2% | — | $105.2M | $29.7M | $75.6M | Oct 31 |
| Q2 2025 · Jun 30 | $297.1M | +4.6% | 32.8% | $91.2M | $14.6M | +0.9% | — | $9.1M | $24.4M | −$15.3M | Aug 5 |
| Q1 2025 · Mar 31 | $237.6M | −16.5% | 22.8% | $46.6M | $4.9M | −66.6% | — | $45.8M | $16M | $29.8M | May 6 |
| Q4 2024 · Dec 31derived | $290.1M | −2.4% | 34.0% | $92M | $15M | +4.9% | — | $132.5M | $13.5M | $119M | Mar 4 |
| Q3 2024 · Sep 30 | $277M | −13.9% | 42.2% | $109.7M | $18.1M | +37.3% | — | $126.1M | $15.5M | $110.5M | Oct 31 |
| Q2 2024 · Jun 30 | $284.2M | — | 35.6% | $93.6M | $14.4M | — | — | $121.9M | $10.2M | $111.7M | Aug 6 |
| Q1 2024 · Mar 31 | $284.7M | — | 35.9% | $95.1M | $14.8M | — | — | $104.6M | $9.8M | $94.8M | May 2 |
| Q4 2023 · Dec 31derived | $297.3M | — | 33.9% | $92.8M | $14.3M | — | — | $107.7M | $12.8M | $94.8M | Mar 4 |
| Q3 2023 · Sep 30 | $321.7M | — | 28.9% | $86.2M | $13.2M | — | — | $100.9M | $16.8M | $84.1M | Nov 6 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $1.2B | 29.8% | $319.6M | $48.7M | 4.2% | — | $280.5M | $78.8M | $201.7M | — | — |
| FY2024 · to Dec 31 | $1.1B | 36.9% | $390.4M | $62.4M | 5.5% | — | $485M | $49M | $436M | — | — |
| FY2023 · to Dec 31 | $1.2B | 32.5% | $357.7M | $54.3M | 4.6% | — | $452M | $46.8M | $405.2M | — | — |
| FY2022 · to Dec 31 | $1.6B | 23.7% | $347.7M | $64.2M | 4.0% | — | $463.7M | $54.1M | $409.6M | — | — |
| FY2021 · to Dec 31 | $1.2B | 36.4% | $410.7M | $82.5M | 6.8% | — | $408.4M | $81.2M | $327.3M | — | — |
| FY2020 · to Dec 31 | $966.7M | 39.2% | $353M | $66.2M | 6.8% | — | $373.4M | $37M | $336.4M | — | — |
Every number comes from Westlake Chemical Partners LP's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.